Lacktman Quoted on Personalized Medicine in Florida
January 28, 2011
Tampa Bay Business Journal
Foley Senior Counsel Nathaniel Lacktman was quoted in an article that appeared in the Tampa Bay Business Journal on January 28, 2011 titled “Clinical trials seen as driving economic sector; M2Gen’s presence helping.” Lacktman discusses the efforts of M2Gen, the for-profit subsidiary of Moffitt Cancer Center, to help position the Tampa Bay region as a national leader in drug development. He states that M2Gen’s work should draw drug developers, physicians and other service providers to the area.
People
Related News
August 17, 2026
In the News
Louis Lehot Weighs in on Acceleration of Software Industry M&A
Foley & Lardner LLP partner Louis Lehot shared perspective on the acceleration of software industry consolidation in the Law360 article, "$1.3B Airtable Deal Highlights Software M&A Revival."
August 17, 2026
In the News
Trey McDonald III and James Carlos McFall Discuss Challenges Facing Student-Athletes in Evolving NIL Era
Foley & Lardner LLP partners Trey McDonald III and James Carlos McFall were featured in the Law360’s article, “Young Athletes Are Wising Up, But Attys Say They're Still Kids,” discussing the challenges facing college student-athletes in the evolving name, image, and likeness landscape.
August 14, 2026
In the News
Foley Attorneys Examine Trade Compliance Implications of New Section 232 Polysilicon Measures
Foley & Lardner LLP attorneys Gregory Husisian, Sunita Paknikar, Annie Tsai, and John Turlais were highlighted in International Trade Today for their insights on new trade measures affecting polysilicon and its derivatives that could reshape import compliance.